Angelo Ceci

1.9k total citations
40 papers, 1.5k citations indexed

About

Angelo Ceci is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Angelo Ceci has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cellular and Molecular Neuroscience, 22 papers in Molecular Biology and 8 papers in Pharmacology. Recurrent topics in Angelo Ceci's work include Neurotransmitter Receptor Influence on Behavior (17 papers), Receptor Mechanisms and Signaling (12 papers) and Neuroscience and Neuropharmacology Research (11 papers). Angelo Ceci is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (17 papers), Receptor Mechanisms and Signaling (12 papers) and Neuroscience and Neuropharmacology Research (11 papers). Angelo Ceci collaborates with scholars based in Germany, United States and Italy. Angelo Ceci's co-authors include Edward D. French, Franco Borsini, Rolf‐Detlef Treede, Henri Doods, Andreas H. Luippold, Bastian Hengerer, René Fuertig, Silvio Garattini, Tiziana Mennini and Kirsten Arndt and has published in prestigious journals such as Biological Psychiatry, FEBS Letters and Pain.

In The Last Decade

Angelo Ceci

39 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angelo Ceci Germany 21 835 521 335 282 237 40 1.5k
Arthur J. Mayorga United States 19 812 1.0× 387 0.7× 258 0.8× 213 0.8× 148 0.6× 27 1.6k
Lynne E. Rueter United States 28 779 0.9× 780 1.5× 250 0.7× 224 0.8× 226 1.0× 51 1.8k
Stephen D. Mague United States 16 910 1.1× 547 1.0× 259 0.8× 171 0.6× 171 0.7× 19 1.7k
Franck Chenu France 17 747 0.9× 426 0.8× 162 0.5× 307 1.1× 371 1.6× 23 1.7k
Caroline A. Stewart United Kingdom 18 570 0.7× 258 0.5× 197 0.6× 261 0.9× 268 1.1× 27 1.3k
Joseph H. Porter United States 20 944 1.1× 451 0.9× 141 0.4× 275 1.0× 278 1.2× 89 1.7k
Beata Legutko Poland 25 742 0.9× 356 0.7× 362 1.1× 298 1.1× 376 1.6× 41 1.8k
Serge Gobaille France 25 1.2k 1.4× 561 1.1× 235 0.7× 150 0.5× 129 0.5× 53 1.9k
Antonio Caprioli Italy 25 530 0.6× 327 0.6× 403 1.2× 319 1.1× 95 0.4× 38 1.5k
Karen E. Asin United States 29 1.5k 1.7× 760 1.5× 297 0.9× 360 1.3× 171 0.7× 71 2.4k

Countries citing papers authored by Angelo Ceci

Since Specialization
Citations

This map shows the geographic impact of Angelo Ceci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Ceci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Ceci more than expected).

Fields of papers citing papers by Angelo Ceci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelo Ceci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Ceci. The network helps show where Angelo Ceci may publish in the future.

Co-authorship network of co-authors of Angelo Ceci

This figure shows the co-authorship network connecting the top 25 collaborators of Angelo Ceci. A scholar is included among the top collaborators of Angelo Ceci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelo Ceci. Angelo Ceci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castelli, Germana, Angelo Ceci, Giovanni Sette, et al.. (2025). CFTR Modulator Response in Nasal Organoids Derived from People with Cystic Fibrosis. Cells. 14(23). 1914–1914.
2.
Just, Stefan, Angelo Ceci, Boris Ferger, et al.. (2022). P376. Preclinical Pharmacological Characterization of the Selective NR2b Negative Allosteric Modulator BI 1569912 With Potential to Treat MDD. Biological Psychiatry. 91(9). S239–S239. 1 indexed citations
3.
Doods, Henri, et al.. (2016). Duloxetine and 8-OH-DPAT, but not fluoxetine, reduce depression-like behaviour in an animal model of chronic neuropathic pain. Neuroscience Letters. 619. 162–167. 25 indexed citations
4.
Fuertig, René, Damiano Azzinnari, Giorgio Bergamini, et al.. (2015). Mouse chronic social stress increases blood and brain kynurenine pathway activity and fear behaviour: Both effects are reversed by inhibition of indoleamine 2,3-dioxygenase. Brain Behavior and Immunity. 54. 59–72. 113 indexed citations
5.
Bartolozzi, Alessandra, Pier F. Cirillo, Eugene R. Hickey, et al.. (2014). Selective CB2 receptor agonists. Part 3: The optimization of a piperidine-based series that demonstrated efficacy in an in vivo neuropathic pain model. Bioorganic & Medicinal Chemistry Letters. 25(3). 587–592. 12 indexed citations
6.
Ferger, Boris, et al.. (2010). Flibanserin, a drug intended for treatment of hypoactive sexual desire disorder in pre-menopausal women, affects spontaneous motor activity and brain neurochemistry in female rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 381(6). 573–579. 15 indexed citations
7.
Ceci, Angelo, et al.. (2009). Effect of high trait anxiety on mechanical hypersensitivity in male rats. Neuroscience Letters. 464(3). 160–164. 39 indexed citations
8.
Doods, Henri, et al.. (2009). Depression-like behaviour in rats with mononeuropathy is reduced by the CB2-selective agonist GW405833. Pain. 143(3). 206–212. 115 indexed citations
9.
Doods, Henri, et al.. (2008). Anxiety-like behaviour in rats with mononeuropathy is reduced by the analgesic drugs morphine and gabapentin. Pain. 139(2). 349–357. 107 indexed citations
11.
Weiser, Thomas, Michael Brenner, Angelo Ceci, et al.. (1999). BIIR 561 CL: A Novel Combined Antagonist of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptors and Voltage-Dependent Sodium Channels with Anticonvulsive and Neuroprotective Properties. Journal of Pharmacology and Experimental Therapeutics. 289(3). 1343–1349. 8 indexed citations
12.
Ceci, Angelo & Franco Borsini. (1996). Effects of desipramine and maprotiline on the coeruleus-cortical noradrenergic system in anaesthetized rats. European Journal of Pharmacology. 312(2). 189–193. 8 indexed citations
13.
Borsini, Franco, et al.. (1995). BIMT 17, a 5-HT1A receptor agonist/5-HT2A receptor antagonist, directly activates postsynaptic 5-HT inhibitory responses in the rat cerebral cortex. Naunyn-Schmiedeberg s Archives of Pharmacology. 352(3). 283–90. 45 indexed citations
15.
Ceci, Angelo, et al.. (1994). Repeated treatment with fluoxetine decreases the number of spontaneously active cells per track in frontal cortex. European Journal of Pharmacology. 271(1). 231–234. 11 indexed citations
16.
Ceci, Angelo, et al.. (1993). Effect of fluoxetine on the spontaneous electrical activity of fronto-cortical neurons. European Journal of Pharmacology. 250(3). 461–464. 13 indexed citations
18.
Volonté, Marina, Angelo Ceci, & Franco Borsini. (1992). Effect of haloperidol and clozapine on (+)SKF 10,047-induced dopamine release: role of 5-HT3 receptors. European Journal of Pharmacology. 213(1). 163–164. 12 indexed citations
19.
French, Edward D. & Angelo Ceci. (1990). Non-competitive antagonists are potent activators of ventral tegmental A10 dopamine neurons. Neuroscience Letters. 119(2). 159–162. 145 indexed citations
20.
Ceci, Angelo, et al.. (1988). Activation of the A10 mesolimbic system by the σ-receptor agonist (+)SKF 10,047 can be blocked by rimcazole, a novel putative antipsychotic. European Journal of Pharmacology. 154(1). 53–57. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026